"Common terminology" is not found on TREX in Finnish-English direction
Try Searching In English-Finnish (Common terminology)

Low quality sentence examples

National Cancer Institute(NCI) Common Terminology Criteria for Adverse Events.
National Cancer Institute(NCI) Common Terminology Criteria for Adverse Events.
Toksisuuden vaikeusasteluokitus: National Cancer Institute Common Terminology Criteria for Adverse Events.
Toxicity grades are in accordance with National Cancer Institute Common Terminology Criteria for Adverse Events.
Haittavaikutusten asteet perustuvat NCI: n(National Cancer Institute) CTCAE-luokitukseen Common Terminology Criteria for Adverse Events.
Grades are based on the National Cancer Institute(NCI) Common Terminology Criteria for Adverse Events CTCAE.
Vaikeusasteet perustuvat National Cancer Instituten(NCI: n) Common Terminology Criteria for Adverse Events-luokitukseen(CTCAE) v3.0.
Grading based on National Cancer Institute(NCI) Common Terminology Criteria for Adverse Events(CTCAE) v3.0.
Huomautus: Toksisuusasteet perustuvat NCI-CTCAE(National Cancer Institute Common Terminology Criteria for Adverse Events)-luokituksen versioon 4.
Note: Toxicity grades are in accordance with National Cancer Institute Common Terminology Criteria for Adverse Events Version 4.0 NCI-CTCAE v4.
Annosta on muutettava, jos potilaalla esiintyy seuraavia haittavaikutuksia gradus-arvot viittaavat CTCAE 4.0-luokitukseen, Common Terminology Criteria for Adverse Events.
Dose modifications should be made if patients experience the following adverse reactions Grades refer to Common Terminology Criteria for Adverse Events CTCAE 4.0.
Jos potilaalla ilmenee sietämätön tai vakava ihoreaktio(≥ luokka 3; Common Terminology Criteria for Adverse Events,
If a patient experiences an intolerable or severe skin reaction( grade 3; Common Terminology Criteria for Adverse Events,
Huom.: Haittavaikutusten vaikeusasteluokat ovat NCI-CTCAE v.4-kriteerien(National Cancer Institute Common Terminology Criteria for Adverse Events Version 4.0) mukaiset.
Note: toxicity grades are in accordance with National Cancer Institute Common Terminology Criteria for Adverse Events Version 4.0 NCI-CTCAE v.4.
Iclusigiin liittyy vaikeaa(Yhdysvaltain National Cancer Institute-syöpäinstituutin Common Terminology Criteria for Adverse Events-kriteerien aste 3
Iclusig is associated with severe(National Cancer Institute Common Terminology Criteria for Adverse Events grade 3
Kaikki haittavaikutukset vaikeusasteesta riippumatta on raportoitu NCI-CTCAE-kriteerien(National Cancer Institute Common Terminology Criteria for Adverse Events) version 3 mukaan, ellei toisin ilmoiteta.
All reporting is based on ADRs of all grades using National Cancer Institute- Common Terminology Criteria for Adverse Events v 3.0 except where noted.
A Huom.: Kliinisten haittatapahtumien voimakkuus on luokiteltu National Cancer Instituten(NCI) haittavaikutusten CTCAE-luokituksen(Common Terminology Criteria for Adverse Events) kriteerien version 4.0.
A Note: The intensity of clinical adverse events graded by the National Cancer Institute(NCI) Common Terminology Criteria for Adverse Events(CTCAE) version 4.0.
NCI CTCAE v 4 National Cancer Institute Common Terminology Criteria for Adverse Events version 4 Kansallisen syöpäinstituutin yleiset terminologiakriteerit haittavaikutuksille, versio 4.
NCI CTCAE v 4.0 National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0.
Hematologisia haittavaikutuksia[kaikki Common Terminology Criteria for Adverse Events(CTCAE)-luokituksen vaikeusasteet]
Haematological adverse drug reactions(any Common Terminology Criteria for Adverse Events[CTCAE]
C Common Terminology Criteria for Adverse Events-luokituksen(CTCAE)
C Common Terminology Criteria for Adverse Events(CTCAE)
Huom.: Toksisuus on luokiteltu NCI-CTCAE-haittavaikutusluokituksen(National Cancer Institute Common Terminology Criteria for Adverse Events) version 4 mukaan. a Suositukset hormonikorvaushoidon käytöstä on annettu kohdassa 4.4.
Note: Toxicity grades are in accordance with National Cancer Institute Common Terminology Criteria for Adverse Events Version 4.0(NCI-CTCAE v4). a Recommendation for the use of hormone replacement therapy is provided in section 4.4.
joiden vaikeusaste on vähintään 2 NCI CTCAE- luokituksen(National Cancer Institute Common Terminology Criteria for Adverse Events- luokituksen) mukaan.
toxicity greater than or equal to grade 2 on the National Cancer Institute Common Terminology Criteria for Adverse Events NCI CTCAE.
Vaikea-asteiset haittavaikutukset(määritelty National Cancer Institute Common Terminology Criteria for Adverse Events[NCI CTCAE luokka ≥ 3]-luokituksen version 3 mukaan)
Severe adverse events(defined according to National Cancer Institute Common Terminology Criteria for Adverse Events(NCI CTCAE grade≥3) version 3.0) were equally distributed between
joiden vaikeusaste on vähintään 3 NCI CTCAE- luokituksen(National Cancer Institute Common Terminology Criteria for Adverse Events)
left ventricular ejection fraction(LVEF) that are National Cancer Institute Common Terminology Criteria for Adverse Events(NCI CTCAE)
tutkimusryhmän tavallisten haittavaikutusten luokitus) tai” Common Terminology Criteria for Adverse Events(CTCAE)
Common Toxicity Criteria(version 1) or the Common Terminology Criteria for Adverse Events(CTCAE)
Suurin osa haittavaikutuksista oli vaikeusasteeltaan gradus 1 tai 2. yleisimmät Yhdysvaltain kansallisen syöpäinstituutin yleisten haittavaikutusten luokituksen(National Cancer Institute- Common Terminology Criteria for Adverse Events[NCI- CTCAE])
The majority of ADRs reported were of Grade 1 or 2 severity. the most common National Cancer Institute- Common Terminology Criteria for Adverse Events(NCI-CTCAE) Grade≥ 3 ADRs(> 2%) were thrombocytopenia, increased transaminases,